BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36372988)

  • 1. Serum GDF9 and BMP15 as potential markers of ovarian function in women with and without polycystic ovary syndrome.
    Riepsamen AH; Donoghoe MW; Indran IR; Hechtman L; Robertson DM; Gilchrist RB; Ledger WL; Yong EL
    Clin Endocrinol (Oxf); 2023 Apr; 98(4):567-577. PubMed ID: 36372988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Concentrations of Oocyte-Secreted Factors BMP15 and GDF9 During IVF and in Women With Reproductive Pathologies.
    Riepsamen AH; Chan K; Lien S; Sweeten P; Donoghoe MW; Walker G; Fraison EHJ; Stocker WA; Walton KL; Harrison CA; Ledger WL; Robertson DM; Gilchrist RB
    Endocrinology; 2019 Oct; 160(10):2298-2313. PubMed ID: 31211369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries.
    Kristensen SG; Kumar A; Mamsen LS; Kalra B; Pors SE; Bøtkjær JA; Macklon KT; Fedder J; Ernst E; Hardy K; Franks S; Andersen CY
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3374-e3383. PubMed ID: 35511085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced and delayed expression of GDF9 and BMP15 in ovarian tissues from women with polycystic ovary syndrome.
    Wei LN; Huang R; Li LL; Fang C; Li Y; Liang XY
    J Assist Reprod Genet; 2014 Nov; 31(11):1483-90. PubMed ID: 25172094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenotypic diversity in per-follicle anti-Müllerian hormone production in polycystic ovary syndrome.
    Alebić MŠ; Stojanović N; Duhamel A; Dewailly D
    Hum Reprod; 2015 Aug; 30(8):1927-33. PubMed ID: 26048913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic variation in anti-Mullerian hormone (AMH) production per follicle in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovarian morphology (PCOM): an observational cross-sectional study.
    Bhide P; Kulkarni A; Dilgil M; Dhir P; Shah A; Gudi A; Homburg R
    Gynecol Endocrinol; 2017 Oct; 33(10):801-806. PubMed ID: 28454499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Change and significance of growth differentiation factor 9 and bone morphogenetic protein expression during oocyte maturation in polycystic ovary syndrome patients with ovarian stimulation].
    Wei LN; Fang C; Huang R; Li LL; Zhang MF; Liang XY
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):818-22. PubMed ID: 23302121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of controlled ovarian stimulation on the expression of GDF9 and BMP15 in oocytes from women with PCOS.
    Wei LN; Li LL; Fang C; Huang R; Liang XY
    J Assist Reprod Genet; 2013 Oct; 30(10):1313-8. PubMed ID: 23912750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The fundamental role of bone morphogenetic protein 15 in ovarian function and its involvement in female fertility disorders.
    Persani L; Rossetti R; Di Pasquale E; Cacciatore C; Fabre S
    Hum Reprod Update; 2014; 20(6):869-83. PubMed ID: 24980253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society.
    Dewailly D; Lujan ME; Carmina E; Cedars MI; Laven J; Norman RJ; Escobar-Morreale HF
    Hum Reprod Update; 2014; 20(3):334-52. PubMed ID: 24345633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell expression analysis of BMP15 and GDF9 in mature oocytes and BMPR2 in cumulus cells of women with polycystic ovary syndrome undergoing controlled ovarian hyperstimulation.
    de Resende LO; Vireque AA; Santana LF; Moreno DA; de Sá Rosa e Silva AC; Ferriani RA; Scrideli CA; Reis RM
    J Assist Reprod Genet; 2012 Oct; 29(10):1057-65. PubMed ID: 22825968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substituting serum anti-Müllerian hormone for polycystic ovary morphology increases the number of women diagnosed with polycystic ovary syndrome: a community-based cross-sectional study.
    Bell RJ; Islam RM; Skiba MA; Herbert D; Martinez Garcia A; Davis SR
    Hum Reprod; 2021 Dec; 37(1):109-118. PubMed ID: 34741176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone (AMH), inhibin-α, growth differentiation factor 9 (GDF9), and bone morphogenic protein-15 (BMP15) mRNA and protein are influenced by photoperiod-induced ovarian regression and recrudescence in Siberian hamster ovaries.
    Shahed A; Young KA
    Mol Reprod Dev; 2013 Nov; 80(11):895-907. PubMed ID: 23877969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oocyte-Derived Factors (GDF9 and BMP15) and FSH Regulate AMH Expression Via Modulation of H3K27AC in Granulosa Cells.
    Roy S; Gandra D; Seger C; Biswas A; Kushnir VA; Gleicher N; Kumar TR; Sen A
    Endocrinology; 2018 Sep; 159(9):3433-3445. PubMed ID: 30060157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
    Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
    Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced?
    Eilertsen TB; Vanky E; Carlsen SM
    Hum Reprod; 2012 Aug; 27(8):2494-502. PubMed ID: 22693172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Aspects and Clinical Relevance of GDF9 and BMP15 in Ovarian Function.
    Belli M; Shimasaki S
    Vitam Horm; 2018; 107():317-348. PubMed ID: 29544636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oocyte-Secreted Serum Biomarkers GDF9 and BMP15 in Women with Endometriosis.
    Shamsa A; Gilchrist RB; Robertson DM; Rodgers RJ; Donoghoe MW; Ledger WL; Abbott JA; Riepsamen AH
    Reprod Sci; 2023 May; 30(5):1521-1527. PubMed ID: 36380138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.